Holdings
ARCH Venture Management, LLC
As of Sep 30, 2026, ARCH Venture Management, LLC reported 16 positions worth US$1.61B. Largest: Kardigan, Inc., Parabilis Medicines, Inc. and Vir Biotechnology, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Kardigan, Inc. | 15M | US$222M | new | Sep 30, 2026 |
| Parabilis Medicines, Inc. | 6.41M | US$207M | no change | Sep 30, 2026 |
| Vir Biotechnology, Inc. | 12.7M | US$142M | no change | Sep 30, 2026 |
| Sana Biotechnology, Inc. | 45.9M | US$134M | new | Sep 30, 2026 |
| Seaport Therapeutics, Inc. | 6.29M | US$127M | no change | Sep 30, 2026 |
| Rapport Therapeutics, Inc. | 3.73M | US$125M | no change | Sep 30, 2026 |
| Scholar Rock Holding Corporation | 2.35M | US$113M | new | Sep 30, 2026 |
| Maze Therapeutics, Inc. | 4.12M | US$112M | no change | Sep 30, 2026 |
| Beam Therapeutics Inc. | 4.54M | US$111M | no change | Sep 30, 2026 |
| Erasca, Inc. | 7.09M | US$104M | no change | Sep 30, 2026 |